Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine

Beda Brichacek, Susan Swindells, Edward N. Janoff, Samuel Pirruccello, Mario Stevenson

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

Primary factors that influence virus burden during human immunodeficiency virus type 1 (HIV-1) disease progression remain a fundamental issue in pathogenesis. Because pneumococcal vaccine is routinely given to HIV-1-infected patients and replication of HIV-1 within CD4 T cells is dependent on the activation state of the cell, it was investigated whether the T cell activation that enhances the immune response to vaccines may also enhance HIV-1 replication. Vaccination of asymptomatic HIV-1-infected patients led to rapid and significant increases in virus burden in some patients. The magnitude of these increases correlated significantly with the extent of the antibody response to the vaccination. Thus, antigenic stimulation by vaccines designed to prevent secondary infections may promote HIV-1 replication in certain patients. These findings provide a window for examining HIV-1 pathogenesis and for determining the appropriate preventive measures against other diseases in HIV-1-infected persons.

Original languageEnglish (US)
Pages (from-to)1191-1199
Number of pages9
JournalJournal of Infectious Diseases
Volume174
Issue number6
DOIs
StatePublished - Jan 1 1996

Fingerprint

Pneumococcal Vaccines
HIV-1
Virus Replication
Vaccination
Vaccines
Viruses
T-Lymphocytes
Virus Diseases
Coinfection
Antibody Formation
Disease Progression

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. / Brichacek, Beda; Swindells, Susan; Janoff, Edward N.; Pirruccello, Samuel; Stevenson, Mario.

In: Journal of Infectious Diseases, Vol. 174, No. 6, 01.01.1996, p. 1191-1199.

Research output: Contribution to journalArticle

@article{0326e720e6b04c40b4135fda44011f52,
title = "Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine",
abstract = "Primary factors that influence virus burden during human immunodeficiency virus type 1 (HIV-1) disease progression remain a fundamental issue in pathogenesis. Because pneumococcal vaccine is routinely given to HIV-1-infected patients and replication of HIV-1 within CD4 T cells is dependent on the activation state of the cell, it was investigated whether the T cell activation that enhances the immune response to vaccines may also enhance HIV-1 replication. Vaccination of asymptomatic HIV-1-infected patients led to rapid and significant increases in virus burden in some patients. The magnitude of these increases correlated significantly with the extent of the antibody response to the vaccination. Thus, antigenic stimulation by vaccines designed to prevent secondary infections may promote HIV-1 replication in certain patients. These findings provide a window for examining HIV-1 pathogenesis and for determining the appropriate preventive measures against other diseases in HIV-1-infected persons.",
author = "Beda Brichacek and Susan Swindells and Janoff, {Edward N.} and Samuel Pirruccello and Mario Stevenson",
year = "1996",
month = "1",
day = "1",
doi = "10.1093/infdis/174.6.1191",
language = "English (US)",
volume = "174",
pages = "1191--1199",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine

AU - Brichacek, Beda

AU - Swindells, Susan

AU - Janoff, Edward N.

AU - Pirruccello, Samuel

AU - Stevenson, Mario

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Primary factors that influence virus burden during human immunodeficiency virus type 1 (HIV-1) disease progression remain a fundamental issue in pathogenesis. Because pneumococcal vaccine is routinely given to HIV-1-infected patients and replication of HIV-1 within CD4 T cells is dependent on the activation state of the cell, it was investigated whether the T cell activation that enhances the immune response to vaccines may also enhance HIV-1 replication. Vaccination of asymptomatic HIV-1-infected patients led to rapid and significant increases in virus burden in some patients. The magnitude of these increases correlated significantly with the extent of the antibody response to the vaccination. Thus, antigenic stimulation by vaccines designed to prevent secondary infections may promote HIV-1 replication in certain patients. These findings provide a window for examining HIV-1 pathogenesis and for determining the appropriate preventive measures against other diseases in HIV-1-infected persons.

AB - Primary factors that influence virus burden during human immunodeficiency virus type 1 (HIV-1) disease progression remain a fundamental issue in pathogenesis. Because pneumococcal vaccine is routinely given to HIV-1-infected patients and replication of HIV-1 within CD4 T cells is dependent on the activation state of the cell, it was investigated whether the T cell activation that enhances the immune response to vaccines may also enhance HIV-1 replication. Vaccination of asymptomatic HIV-1-infected patients led to rapid and significant increases in virus burden in some patients. The magnitude of these increases correlated significantly with the extent of the antibody response to the vaccination. Thus, antigenic stimulation by vaccines designed to prevent secondary infections may promote HIV-1 replication in certain patients. These findings provide a window for examining HIV-1 pathogenesis and for determining the appropriate preventive measures against other diseases in HIV-1-infected persons.

UR - http://www.scopus.com/inward/record.url?scp=0029852819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029852819&partnerID=8YFLogxK

U2 - 10.1093/infdis/174.6.1191

DO - 10.1093/infdis/174.6.1191

M3 - Article

C2 - 8940208

AN - SCOPUS:0029852819

VL - 174

SP - 1191

EP - 1199

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -